Abstract
As a result of the synovial sarcoma associated t(X;18) translocation, the human SYT gene on chromosome 18 is fused to either the SSX1 or the SSX2 gene on the X chromosome. Although preliminary evidence indicates that the (fusion) proteins encoded by these genes may play a role in transcriptional regulation, little is known about their exact function. We set out to isolate interacting proteins through yeast two hybrid screening of a human cDNA library using SYT as a bait. Of the positive clones isolated, two were found to correspond to the acute leukemia t(10;11) associated AF10 gene, a fusion partner of MLL. Confirmation of these results was obtained via co-immunoprecipitation of endogenous and exogenous, epitope-tagged, SYT and AF10 proteins from cell line extracts and colocalization of epitope-tagged SYT and AF10 proteins in transfected cells. Subsequent sequential mutation analysis revealed a highly specific interaction of N-terminal SYT fragments with C-terminal AF10 fragments. The N-terminal interaction domain of the SYT protein was also found to be present in several SYT orthologs and homologs. The C-terminal interaction domain of AF10 is located outside known functional domains. Based on these results, a model is proposed in which the SYT and AF10 proteins act in concert as bipartite transcription factors. This model has implications for the molecular mechanisms underlying the development of both human synovial sarcomas and acute leukemias.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aasland R, Gibson TJ, Stewart AF . 1995 Trends Biochem. Sci. 20: 56–59
Bairoch A, Bucher P, Hofmann K . 1997 Nucleic Acids Res. 25: 217–221
Bellefroid EJ, Poncelet DA, Lecocq PJ, Revelant O, Martial JA . 1991 Proc. Natl. Acad. Sci. USA 88: 3608–3612
Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G . 1997 Hum. Mol. Genet. 6: 1559–1564
Chaplin T, Ayton P, Bernard OA, Saha V, Della Valle V, Hillion J, Gregorini A, Lillington D, Berger R, Young BD . 1995a Blood 85: 1435–1441
Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R, Young BD . 1995b Blood 86: 2073–2076
Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, Gusterson BA, Cooper CS . 1994 Nat. Genet. 7: 502–508
Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS . 1995 EMBO J. 14: 2333–2340
de Bruijn DRH, Oerlemans F, Hendriks W, Baats E, Ploemacher R, Wieringa B, Geurts van Kessel A . 1994 Differentiation 58: 141–148
de Bruijn DRH, Baats E, Zechner U, de Leeuw B, Balemans M, Olde Weghuis D, Hirning-Folz U, Geurts van Kessel A . 1996 Oncogene 13: 643–648
de Bruijn DRH, Kater-Baats E, Eleveld M, Merkx G, Geurts van Kessel A . 2001 Cytogenet. Cell Genet. in press
de Leeuw B, Balemans M, Geurts van Kessel A . 1996 Cytogenet. Cell Genet. 73: 179–183
de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A . 1995 Hum. Mol. Genet. 4: 1097–1099
de Leeuw B, Suijkerbuijk RF, Olde Weghuis D, Meloni AM, Stenman G, Kindblom LG, Balemans M, van den Berg E, Molenaar WM, Sandberg AA, Geurts van Kessel A . 1994 Cancer Genet. Cytogenet. 73: 89–94
Djabali M, Selleri L, Parry P, Bower M, Young BD, Evans GA . 1992 Nat. Genet. 2: 113–118
dos Santos NR, de Bruijn DRH, Balemans M, Janssen B, Gartner F, Lopes JM, de Leeuw B, Geurts van Kessel A . 1997 Hum. Mol. Genet. 6: 1549–1558
dos Santos NR, de Bruijn DRH, Kater-Baats E, Otte AP, Geurts van Kessel A . 2000a Exp. Cell Res. 256: 192–202
dos Santos NR, Torensma R, de Vries TJ, Schreurs MW, de Bruijn DRH, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GN, Geurts van Kessel A . 2000b Cancer Res. 60: 1654–1662
Eid JE, Kung AL, Scully R, Livingston DM . 2000 Cell 102: 839–848
Epstein H . 1992 Bioessays 14: 411–413
Freemont PS . 1993 Ann. N.Y. Acad. Sci. 684: 174–192
Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, Rauscher III FJ . 1996 Genes Dev. 10: 2067–2078
Geurts van Kessel A, dos Santos NR, Simons A, de Bruijn DRH, Forus A, Fodstad O, Myklebost O, Balemans M, Baats E, Olde Weghuis D, Suijkerbuijk RF, van den Berg E, Molenaar WM, de Leeuw B . 1997 Cancer Genet. Cytogenet. 95: 67–73
Gure AO, Tureci O, Sahin U, Tsang S, Scanlan MJ, Jager E, Knuth A, Pfreundschuh M, Old LJ, Chen YT . 1997 Int. J. Cancer 72: 965–971
Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, Gronenborn AM, Clore GM . 1997 Nat. Struct. Biol. 4: 657–665
Jenuwein T, Laible G, Dorn R, Reuter G . 1998 Cell. Mol. Life Sci. 54: 80–93
Kanazawa S, Driscoll M, Struhl K . 1988 Mol. Cell. Biol. 8: 664–673
Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M . 1998 N. Engl. J. Med. 338: 153–160
Kim SS, Chen YM, O'Leary E, Witzgall R, Vidal M, Bonventre JV . 1996 Proc. Natl. Acad. Sci. USA 93: 15299–15304
Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC . 1998 Oncogene 17: 2013–2018
Linder B, Jones LK, Chaplin T, Mohd-Sarip A, Heinlein UA, Young BD, Saha V . 1998 Biochim. Biophys. Acta. 1443: 285–296
Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P, Verrijzer CP, Saha V . 2000 J. Mol. Biol. 299: 369–378
Ma Q, Alder H, Nelson KK, Chatterjee D, Gu Y, Nakamura T, Canaani E, Croce CM, Siracusa LD, Buchberg AM . 1993 Proc. Natl. Acad. Sci. USA 90: 6350–6354
Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher III FJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4509–4513
Moosmann P, Georgiev O, Le Douarin B, Bourquin JP, Schaffner W . 1996 Nucleic Acids Res. 24: 4859–4867
Pawson T . 1995 Nature 373: 573–580
Rozenblatt-Rosen O, Rozovskaia T, Burakov D, Sedkov Y, Tillib S, Blechman J, Nakamura T, Croce CM, Mazo A, Canaani E . 1998 Proc. Natl. Acad. Sci. USA 95: 4152–4157
Saha V, Chaplin T, Gregorini A, Ayton P, Young BD . 1995 Proc. Natl. Acad. Sci. USA 92: 9737–9741
Satijn DP, Gunster MJ, van der Vlag J, Hamer KM, Schul W, Alkema MJ, Saurin AJ, Freemont PS, van Driel R, Otte AP . 1997 Mol. Cell. Biol. 17: 4105–4113
Schlessinger J . 1994 Curr. Opin. Gen. Dev. 4: 25–30
Singh PB . 1994 J. Cell Sci. 107: 2653–2668
Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlen M, Larsson O . 1999 J. Natl. Cancer Inst. 91: 974–975
Slany RK, Lavau C, Cleary ML . 1998 Mol. Cell. Biol. 18: 122–129
Stassen MJ, Bailey D, Nelson S, Chinwalla V, Harte PJ . 1995 Mech. Dev. 52: 209–223
Thaete C, Brett D, Monaghan P, Whitehouse S, Rennie G, Rayner E, Cooper CS, Goodwin G . 1999 Hum. Mol. Genet. 8: 585–591
Tkachuk DC, Kohler S, Cleary ML . 1992 Cell 71: 691–700
Tripoulas N, LaJeunesse D, Gildea J, Shearn A . 1996 Genetics 143: 913–928
Tschiersch B, Hofmann A, Krauss V, Dorn R, Korge G, Reuter G . 1994 EMBO J. 13: 3822–3831
Turc-Carel C, Dal-Cin P, Limon J, Rao U, Li FP, Corson JM, Zimmerman R, Parry DM, Cowan JM, Sandberg AA . 1987 Proc. Natl. Acad. Sci. USA 84: 1981–1985
Verrijzer CP, Tjian R . 1996 Trends Biochem. Sci. 21: 338–342
Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV . 1994 Proc. Natl. Acad. Sci. USA 91: 4514–4518
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Bruijn, D., dos Santos, N., Thijssen, J. et al. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene 20, 3281–3289 (2001). https://doi.org/10.1038/sj.onc.1204419
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204419
Keywords
This article is cited by
-
Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes
Current Oncology Reports (2020)
-
Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer
Cancer and Metastasis Reviews (2015)
-
Reduced expression of SMARCB1/INI1 protein in synovial sarcoma
Modern Pathology (2010)
-
Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration
Laboratory Investigation (2009)
-
The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4
Oncogene (2008)